Detalhe da pesquisa
1.
Effectiveness of Prone Positioning in Nonintubated Intensive Care Unit Patients With Moderate to Severe Acute Respiratory Distress Syndrome by Coronavirus Disease 2019.
Anesth Analg
; 132(1): 25-30, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32947292
2.
Comparison of tracheal intubation conditions between the operating room and intensive care unit: impact of universal videolaryngoscopy.
Br J Anaesth
; 132(5): 984-986, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448268
3.
Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back.
Int J Mol Sci
; 17(9)2016 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27657044
4.
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer.
Mol Cancer
; 13: 223, 2014 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25261936
5.
A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
Int J Cancer
; 135(11): 2633-43, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24752533
6.
Agnostic drug development revisited.
Cancer Treat Rev
; 128: 102747, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763053
7.
Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer.
Radiol Artif Intell
; 6(2): e230118, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294307
8.
Effect of early vs. delayed extubation on functional outcome among patients with acute ischemic stroke treated with endovascular thrombectomy under general anesthesia: the prospective, randomized controlled EDESTROKE trial study protocol.
Trials
; 25(1): 357, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38835061
9.
Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel-Lindau-Disease-Associated Tumors.
Med Sci (Basel)
; 11(3)2023 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37489462
10.
Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens.
Cancer Res Commun
; 3(8): 1662-1671, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645622
11.
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial.
Neuro Oncol
; 25(1): 146-156, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639513
12.
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors.
Clin Cancer Res
; 29(18): 3592-3602, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491846
13.
Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patients.
Oral Oncol
; 140: 106364, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36989964
14.
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas.
Nat Commun
; 14(1): 1359, 2023 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36914652
15.
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials.
Med
; 4(10): 710-727.e5, 2023 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37572657
16.
A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer.
J Cell Mol Med
; 16(10): 2342-9, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22304365
17.
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors.
J Immunother Cancer
; 10(10)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316061
18.
Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma.
Neurooncol Adv
; 4(1): vdac146, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36382109
19.
A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma.
Mol Cancer Ther
; 21(10): 1499-1509, 2022 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35915983
20.
First-In-Human Phase I Study of a Next-Generation, Oral, TGFß Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer.
Clin Cancer Res
; 27(24): 6666-6676, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34548321